CORNOVUS PHARMACEUTICALS

Cornovus Pharmaceuticals is a developer of a heart attack drug used to treat cardiac hypertrophy and heart failure. The technology increases myocardial cyclic guanosine-monophosphate which may play a role in cardia function and reperfusion enables heart attack victims to delay the onset of heart failure after a heart attack or injury. It was founded in 2011 and is headquartered in Farmington, Connecticut.